342 related articles for article (PubMed ID: 7492096)
1. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.
Nakajima R; Kitamura A; Someya K; Tanaka M; Sato K
Antimicrob Agents Chemother; 1995 Jul; 39(7):1517-21. PubMed ID: 7492096
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
3. [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].
Yalçin B; Kalkanci A; Gürelik F; Fidan I; Kustimur S; Ozdek S
Mikrobiyol Bul; 2010 Jan; 44(1):65-70. PubMed ID: 20455400
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.
Tsuchimori N; Hayashi R; Kitamoto N; Asai K; Kitazaki T; Iizawa Y; Itoh K; Okonogi K
Antimicrob Agents Chemother; 2002 May; 46(5):1388-93. PubMed ID: 11959573
[TBL] [Abstract][Full Text] [Related]
5. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
Niwano Y; Kuzuhara N; Goto Y; Munechika Y; Kodama H; Kanai K; Yoshida M; Miyazaki T; Yamaguchi H
Int J Antimicrob Agents; 1999 Aug; 12(3):221-8. PubMed ID: 10461840
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
Singh J; Rimek D; Kappe R
Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
[TBL] [Abstract][Full Text] [Related]
9. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.
Saito H; Tomioka H; Sato K; Dekio S
Antimicrob Agents Chemother; 1994 Dec; 38(12):2877-82. PubMed ID: 7695276
[TBL] [Abstract][Full Text] [Related]
11. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
[No Abstract] [Full Text] [Related]
12. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
Helmerhorst EJ; Reijnders IM; van't Hof W; Simoons-Smit I; Veerman EC; Amerongen AV
Antimicrob Agents Chemother; 1999 Mar; 43(3):702-4. PubMed ID: 10049295
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
Morrissey I; Smith JT
J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.
Nakane T; Iyobe S; Sato K; Mitsuhashi S
Antimicrob Agents Chemother; 1995 Dec; 39(12):2822-6. PubMed ID: 8593031
[TBL] [Abstract][Full Text] [Related]
15. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
17. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
[TBL] [Abstract][Full Text] [Related]
19. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Lu Y; Zhou Z; Mo L; Guo Q; Peng X; Hu T; Zhou X; Ren B; Xu X
Appl Microbiol Biotechnol; 2019 Aug; 103(16):6701-6709. PubMed ID: 31201451
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]